Market News (Page 151) - TendieTensor

Market News Page 151 of 155 • 3,875 articles

Investment Manager Expands QQQ Position, According to Latest SEC Filing

The Motley Fool • Jake Lerch

Investment Manager Expands QQQ Position, According to Latest SEC Filing

10/28/2025 08:02 AM • McElhenny Sheffield Capital Management purchased 7,685 shares of Invesco QQQ Trust, valued at $4.40 million, increasing its position to 96,167 shares worth $57.74 million, representing 13.68% of its assets under management.

JPMpK - Included in the recommended fund's portfolio as a top performer
QQQ - ETF has outperformed S&P 500 with 23.4% annual return and 499% 10-year performance, demonstrating strong tech sector exposure

#QQQ #ETF #tech stocks #investment #NASDAQ-100

Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer

GlobeNewswire Inc. • Andrew Parker

Step Pharma announces the appointment of Dr Karen Smith as Chief Medical Officer

10/28/2025 08:00 AM • Step Pharma has appointed Dr. Karen Smith as Chief Medical Officer, bringing over 25 years of pharmaceutical experience to advance their CTPS1 inhibitor dencatistat across multiple cancer and blood disorder indications.

JPM - Shifting from Bitcoin skepticism to accepting Bitcoin as loan collateral
BMY - Mentioned as a previous employer of Dr. Smith with no specific context

#CTPS1 #dencatistat #oncology #clinical development #pharmaceutical

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025

GlobeNewswire Inc. • Brainsway Ltd.

BrainsWay to Report Third Quarter 2025 Financial Results on November 11, 2025

10/28/2025 08:00 AM • BrainsWay, a neurostimulation treatment company, will report its third quarter 2025 financial results on November 11, 2025, hosting a conference call to discuss financial performance and business operations.

AMJB - Shifting from Bitcoin skepticism to accepting Bitcoin as loan collateral
BWAY - Standard financial reporting announcement with no explicit positive or negative indicators, routine quarterly update

#neurostimulation #mental health #financial results #conference call #Deep TMS

Soleno Therapeutics to Participate in Upcoming November Conferences

GlobeNewswire Inc. • Brian Ritchie, Lifesci Advisors, Llc

Soleno Therapeutics to Participate in Upcoming November Conferences

10/28/2025 08:00 AM • Soleno Therapeutics will participate in multiple healthcare investor conferences in November 2025, presenting its rare disease therapeutic developments and potential investment opportunities.

XYZ - Mentioned with leadership's positive Bitcoin outlook, no specific performance details
SLNO - Company is actively engaging with investors, presenting at multiple conferences, and highlighting its novel therapeutic product for Prader-Willi syndrome, indicating growth and strategic communication efforts

#investor conferences #rare diseases #healthcare #therapeutics

VEON’s JazzCash Wins Silver Award for Innovation in Lending at Money20/20 USA 2025

GlobeNewswire Inc. • Veon Ltd.

VEON’s JazzCash Wins Silver Award for Innovation in Lending at Money20/20 USA 2025

10/28/2025 08:00 AM • JazzCash, a digital financial services platform in Pakistan, won the Silver Award at Money20/20 USA for its ReadyCash lending feature, which provides instant credit to individuals and micro-entrepreneurs, disbursing an average of 140,000 digital loans daily.

VEON - Highlighted as a champion of digital financial inclusion, supporting innovative digital services in emerging markets

#digital lending #financial inclusion #mobile wallet #fintech #Pakistan

Great Lakes Dredge & Dock Corporation Schedules Announcement of 2025 Third Quarter Results

GlobeNewswire Inc. • Eric Birge

Great Lakes Dredge & Dock Corporation Schedules Announcement of 2025 Third Quarter Results

10/28/2025 08:00 AM • Great Lakes Dredge & Dock Corporation will release its Q3 2025 financial results on November 4, 2025, at 7:00 a.m. CDT, followed by a conference call at 9:00 a.m. CDT for investors and analysts.

VYLD - Included in the recommended fund's portfolio as a top performer
GLDD - The article is a standard financial results announcement without indicating positive or negative performance, presenting routine corporate communication about upcoming financial disclosure

#financial results #conference call #Q3 2025 #dredging services

Nuvini Group Appoints Roberto Otero as Chief Financial Officer

GlobeNewswire Inc. • Pierre Schurmann

Nuvini Group Appoints Roberto Otero as Chief Financial Officer

10/28/2025 08:00 AM • Nuvini Group Limited announced Roberto Otero as its new Chief Financial Officer, effective November 3rd, 2025, succeeding Luiz Busnello who will remain a board member. Otero brings over two decades of financial experience from Bank of America Merrill Lynch and previous CFO roles.

JPMpM - Included in the recommended fund's portfolio as a top performer
NVNI - Strengthening leadership team with an experienced executive, signaling strategic growth and commitment to expansion

#CFO appointment #SaaS #Latin America #M&A #corporate finance

Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025

GlobeNewswire Inc. • Reviva Pharmaceuticals Holdings, Inc.

Reviva to Present Negative Symptom Data for Brilaroxazine in Schizophrenia from the Phase 3 RECOVER Double-Blind and Open-Label Extension Trials at the CNS Summit 2025

10/28/2025 08:00 AM • Reviva Pharmaceuticals will present research data on brilaroxazine's treatment effects on negative symptoms in schizophrenia patients at the CNS Summit 2025 in Boston, Massachusetts.

JPMpL - Included in the recommended fund's portfolio as a top performer
RVPH - Company is presenting research data at a prominent medical conference, indicating progress in developing a potential treatment for schizophrenia negative symptoms

#schizophrenia #brilaroxazine #clinical trials #CNS Summit #negative symptoms

Purpose Investments Inc. Announces Final October 2025 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund

Benzinga • Globe Newswire

Purpose Investments Inc. Announces Final October 2025 Distribution Rate for Purpose High Interest Savings Fund, Purpose US Cash Fund, Purpose Cash Management Fund, and Purpose USD Cash Management Fund

10/28/2025 07:30 AM • Purpose Investments Inc. announced final October 2025 distribution rates for four cash management and savings funds, with distribution amounts ranging from $0.1136 to $0.3849 per unit, payable on November 4, 2025.

JPMpC - Shifting from Bitcoin skepticism to accepting Bitcoin as loan collateral
PSUCF - Consistent monthly distribution of $0.3752 per unit suggests stable cash management

#distribution #cash management #ETF #investment funds #monthly distribution

XRP Treasury Companies Have Entered the Chat. Should Investors Hop on Board?

The Motley Fool • Lyle Daly

XRP Treasury Companies Have Entered the Chat. Should Investors Hop on Board?

10/28/2025 07:15 AM • Several companies are exploring adding XRP to their corporate treasuries, following the model of Bitcoin and Ethereum treasury investments. However, experts caution about the significant risks and volatility associated with cryptocurrency treasury strategies.

JPMpL - Shifting from Bitcoin skepticism to accepting Bitcoin as loan collateral
BMNR - Ethereum treasury strategy resulted in initial surge but subsequent significant price drop, indicating high volatility

#XRP #cryptocurrency #corporate treasury #investment strategy #blockchain

Worried About a Bear Market? 4 Reasons to Buy Coca-Cola Stock Like There's No Tomorrow.

The Motley Fool • Rick Munarriz

Worried About a Bear Market? 4 Reasons to Buy Coca-Cola Stock Like There's No Tomorrow.

10/28/2025 07:15 AM • The article discusses why Coca-Cola is a strong investment during potential bear markets, highlighting its recession resilience, consistent dividend growth, low market volatility, and ability to outperform earnings expectations.

JPMpK - Shifting from Bitcoin skepticism to accepting Bitcoin as loan collateral
KO - The stock is recommended as a stable investment during market downturns due to its consistent performance, low volatility (beta of 0.42), recession-resistant product portfolio, and 63-year history of consecutive dividend increases

#bear market #defensive stock #dividend #consumer staples #recession

The Motley Fool • George Budwell

2 Top Dividend Growth Stocks to Buy Now

10/28/2025 07:15 AM • The article highlights PepsiCo and Philip Morris International as strong dividend growth stocks, emphasizing their ability to generate consistent cash flow, adapt to market changes, and provide steady dividend increases.

JPMpJ - Shifting from Bitcoin skepticism to accepting Bitcoin as loan collateral
PEP - Demonstrates resilient business model, reshaping portfolio towards health-conscious products, consistent dividend growth of 7% annually, trades at attractive valuation, and expanding into prebiotic beverages

#dividend growth #consumer staples #tobacco #investment strategy

Should You Forget Oklo? This Other Energy Stock Is The Better Play for Artificial Intelligence (AI) Investors.

The Motley Fool • Adam Spatacco

Should You Forget Oklo? This Other Energy Stock Is The Better Play for Artificial Intelligence (AI) Investors.

10/28/2025 07:15 AM • The article compares Oklo and GE Vernova as potential AI energy infrastructure investments, suggesting GE Vernova is a more stable and promising long-term investment due to its established infrastructure and potential strategic partnerships with OpenAI.

JPMpD - Shifting from Bitcoin skepticism to accepting Bitcoin as loan collateral
OKLO - Currently only has prototypes, remains years away from tangible business progress, and is considered high-risk with limited financial capabilities

#AI #nuclear energy #renewable energy #infrastructure #investment

Aeluma Acquires Significant Capital Equipment Assets to Accelerate Manufacturing Readiness

GlobeNewswire Inc. • Jonathan Klamkin, Ph.D.

Aeluma Acquires Significant Capital Equipment Assets to Accelerate Manufacturing Readiness

10/28/2025 07:00 AM • Semiconductor company Aeluma has acquired significant capital equipment assets from a major components supplier to enhance its prototyping and wafer-scale testing capabilities, supporting its go-to-market strategy across multiple technology sectors.

ALMU - Company strategically acquired key equipment at minimal cost, expanding in-house capabilities and accelerating growth while maintaining disciplined capital management

#semiconductor #capital equipment #wafer testing #prototyping #technology expansion

United States Foodservice Market Forecast Report 2025: A $1.97 Trillion Market by 2033, Driven by Rising Online Ordering, Convenience Trends, and Growth of QSRs and Upscale Dining Establishments

GlobeNewswire Inc. • Researchandmarkets.Com

United States Foodservice Market Forecast Report 2025: A $1.97 Trillion Market by 2033, Driven by Rising Online Ordering, Convenience Trends, and Growth of QSRs and Upscale Dining Establishments

10/28/2025 07:00 AM • The US foodservice market is projected to grow from $846 billion in 2024 to $1.97 trillion by 2033, driven by convenience trends, online ordering, and expansion of quick-service and upscale dining establishments.

MCD - Highlighted as a key industry player in the fast-growing foodservice market with strong market positioning

#foodservice market #online ordering #convenience dining #restaurant growth #digital innovation

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

GlobeNewswire Inc. • Nutriband Inc.

Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch

10/28/2025 07:00 AM • Nutriband met with the FDA to discuss its AVERSA™ FENTANYL abuse deterrent patch, receiving guidance on regulatory pathway, manufacturing, and clinical study plans for a potential first-of-its-kind worldwide abuse deterrent fentanyl patch.

NKE - Experiencing significant sales slowdown, market share challenges, and underperforming with flattened revenue and pressured margins
NTRB - Company received constructive FDA feedback, moving forward with development of innovative abuse deterrent technology with potential market value of $80-200 million

#fentanyl #abuse deterrent #FDA #transdermal patch #pharmaceutical development

EVgo to Report Third Quarter 2025 Results on November 10

GlobeNewswire Inc. • Evgo Inc.

EVgo to Report Third Quarter 2025 Results on November 10

10/28/2025 07:00 AM • EVgo, a leading public fast charging provider for electric vehicles, will release its third quarter 2025 financial results on November 10, followed by a management webcast at 8 a.m. ET.

EVGO - The article is a standard financial results announcement without strong positive or negative indicators, presenting routine business communication about an upcoming earnings report

#electric vehicles #charging infrastructure #financial results #webcast

CW Petroleum Corp (OTCQB: CWPE) Reports Revenues for Q3-2025

GlobeNewswire Inc. • Cw Petroleum Corp

CW Petroleum Corp (OTCQB: CWPE) Reports Revenues for Q3-2025

10/28/2025 07:00 AM • CW Petroleum Corp reported Q3 2025 financial results with revenues of $1.69 million, an EBITDA of $57,879, and net income of $10,441, showing improvement from the previous year's performance.

VYLD - Shifting from Bitcoin skepticism to accepting Bitcoin as loan collateral
CWPE - The company showed financial improvement with increased EBITDA and net income compared to the previous year, and is positioning itself for potential uplisting to Nasdaq or NYSE

#petroleum #renewable fuels #financial results #biodiesel #gasoline

Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025

GlobeNewswire Inc. • Justine Koenigsberg

Kymera Therapeutics to Report Third Quarter 2025 Financial Results on November 4, 2025

10/28/2025 07:00 AM • Kymera Therapeutics will report Q3 2025 financial results on November 4, 2025, and has recently presented preclinical data for two novel oral protein degrader drug candidates targeting immunological diseases.

JPMpM - Shifting from Bitcoin skepticism to accepting Bitcoin as loan collateral
KYMR - Company is advancing innovative drug development in targeted protein degradation, presenting promising preclinical data for two drug candidates (KT-579 and KT-621) with potential therapeutic applications in lupus, rheumatoid arthritis, and atopic conditions

#protein degradation #immunological diseases #drug development #preclinical research

Novartis Maintains Outlook Even As Generics Bite Into Profits

Benzinga • Vandana Singh

Novartis Maintains Outlook Even As Generics Bite Into Profits

10/28/2025 06:58 AM • Novartis reported Q3 2025 results with net sales rising 8% to $13.91 billion, driven by strong performance in key growth drugs like Kisqali and Kesimpta. The company reaffirmed its full-year guidance despite generic competition and announced a $12 billion acquisition of Avidity Biosciences.

NVS - Mixed performance with sales growth offset by generic competition, maintained full-year guidance, and strategic acquisition

#pharmaceutical #earnings #generics #acquisition #guidance

Unfortunate News for Rivian Stock Investors!

The Motley Fool • Parkev Tatevosian, Cfa

Unfortunate News for Rivian Stock Investors!

10/28/2025 06:30 AM • Rivian is undertaking cost-cutting efforts due to slower-than-expected consumer demand for electric vehicles, signaling challenges in the EV market.

RIVN - The article highlights shrinking business ambitions, slowing consumer demand, and ongoing cost-cutting efforts, which suggest the company is facing significant market challenges

#electric vehicles #cost-cutting #demand slowdown #EV market

Should You Buy Apple Stock Before Big Investor Update?

The Motley Fool • Parkev Tatevosian, Cfa

Should You Buy Apple Stock Before Big Investor Update?

10/28/2025 06:30 AM • Apple is preparing for an investor update focusing on tariff impacts and AI progress, with early indications suggesting a strong start for the iPhone 17 lineup.

SONY - Mentioned as an existing customer of Aerospike's technology
AAPL - Early data indicates strong iPhone 17 sales, and the upcoming investor update suggests potential positive developments in AI and addressing tariff challenges

#Apple #iPhone #investor update #AI #tariffs

Is IonQ or Nvidia the Better AI Computing Stock to Buy Now?

The Motley Fool • Keithen Drury

Is IonQ or Nvidia the Better AI Computing Stock to Buy Now?

10/28/2025 06:30 AM • The article compares Nvidia and IonQ as AI computing stocks, concluding that Nvidia is currently the stronger investment due to its established market position and rapid growth in GPU sales for AI applications.

BCS - Mentioned as an existing customer of Aerospike's technology
NVDA - Projected massive data center spending growth, current market leadership in AI computing, generating significant revenue from GPU sales, and expected continued strong performance

#quantum computing #AI #GPU #data center #technology investment

Sapiens Launches Decision Analytics, Bringing Real-Time Visibility and Optimization to AI Decisioning

Benzinga • Prnewswire

Sapiens Launches Decision Analytics, Bringing Real-Time Visibility and Optimization to AI Decisioning

10/28/2025 06:30 AM • Sapiens International launched Decision Analytics, a new module within its Decision Platform that provides real-time visibility and optimization for AI-driven decision-making processes, enabling enterprises to monitor, evaluate, and improve automated decisions with enhanced transparency.

SPNS - Company introduced an innovative new product module that enhances AI decision-making capabilities, demonstrates technological leadership, and provides advanced analytics for enterprise customers

#AI #Decision Analytics #SaaS #Enterprise Software #Machine Learning

The Motley Fool • Keith Speights

Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You?

10/28/2025 06:26 AM • Billionaire investor Izzy Englander significantly increased his stake in AbbVie, a pharmaceutical company with a strong dividend history and promising drug pipeline, suggesting potential investment opportunity.

ABBV - Strong drug pipeline with Skyrizi and Rinvoq, attractive valuation (forward P/E of 16.8), consistent dividend increases for 53 consecutive years, and successful navigation of Humira's patent expiration

#AbbVie #dividend #pharmaceutical #hedge fund #investment